Arcellx Director Sells 6,000 Shares for $450,000
ArcellxArcellx(US:ACLX) The Motley Fool·2026-02-01 10:50

A director at one of the top clinical-stage biotech companies sold 6,000 insider shares towards the end of January 2026 amid the company's stock having an underwhelming performance in 2025. On Jan. 20, 2026, Director David Charles Lubner executed the exercise and immediate sale of 6,000 shares of Arcellx, Inc. (ACLX +0.07%) common stock for a total transaction value of approximately 450,000,asdisclosedinaSECForm4filing.TransactionsummaryMetricValueSharessold(direct)6,000Transactionvalue 450,000, as disclosed in a SEC Form 4 filing.Transaction summaryMetricValueShares sold (direct)6,000Transaction value~450,00 ...